| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a global pharmaceutical company focused on discovering, developing, manufacturing, and marketing prescription medicines for human health. Headquartered in Indianapolis, Indiana, and founded in 1876, the company operates in th..
>Volltext.. |
| 996192.22 Mio. EUR |
| 1036402.83 Mio. EUR |
| 69087.77 Mio. EUR |
| 36168.1 Mio. EUR |
| 23163.01 Mio. EUR |
| 25.55 EUR |
| 47617.31 Mio. EUR |
| 7709.59 Mio. EUR |
| 24354.57 Mio. EUR |
| 0.19 |
| 54.29% |
| 99.64% |
| 5.52 EUR |
| 0.53% |
| 0.57% |
| 15.05.26 - 1.4872811€ 13.02.26 - 1.457352€ >weitere anzeigen... |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 7.212.629 Euro. |
| ELI LILLY, LILLY DEUTSCHLAND |
| 14.08.26 |
|